AUTHOR=Yang Tianlong , Wang Yao , Zhao Qinglong , Guo Xiaohao , Yu Shanshan , Zhao Zeyu , Deng Bin , Huang Jiefeng , Liu Weikang , Su Yanhua , Chen Tianmu TITLE=Age-specific transmission dynamic of mumps: A long-term large-scale modeling study in Jilin Province, China JOURNAL=Frontiers in Public Health VOLUME=10 YEAR=2022 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.968702 DOI=10.3389/fpubh.2022.968702 ISSN=2296-2565 ABSTRACT=Objectives

Despite the adoption of a new childhood immunization program in China, the incidence of mumps remains high. This study aimed to describe the epidemiological characteristics of mumps in Jilin Province from 2005 to 2019 and to assess the transmissibility of mumps virus among the whole population and different subgroups by regions and age groups.

Methods

The Non-age-specific and age-specific Susceptible–Exposed–Pre-symptomatic–Infectious–Asymptomatic–Recovered (SEPIAR) models were fitted to actual mumps incidence data. The time-varying reproduction number (Rt) was used to evaluate and compare the transmissibility.

Results

From 2005 to 2019, a total of 57,424 cases of mumps were reported in Jilin Province. The incidence of mumps was the highest in people aged 5 to 9 years (77.37 per 100,000). The two SEPIAR models fitted the reported data well (P < 0.01). The median transmissibility (Rt) calculated by the two SEPIAR models were 1.096 (range: 1.911 × 10−5–2.192) and 1.074 (range: 0.033–2.114) respectively. The age-specific SEPIAR model was more representative of the actual epidemic of mumps in Jilin Province from 2005–2019.

Conclusions

For mumps control, it is recommended that mumps-containing vaccines (MuCV) coverage be increased nationwide in the 5–9 years age group, either by a mumps vaccine alone or by a combination of vaccines such as measles-mumps-rubella (MMR) vaccine. The coverage of vaccines in Jilin Province should be continuously expanded to establish solid immunity in the population. China needs to redefine the optimal time interval for MuCV immunization.